Deborah Birx
Chief Executive Officer at ARMATA PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 30/03/2024
Profile
Deborah L.
Birx is currently the Chief Executive Officer & Director at Armata Pharmaceuticals, Inc. and a Director at Nanolive SA. Previously, she served as an Independent Director at Innoviva, Inc. from 2021 to 2023.
Dr. Birx completed her undergraduate degree at Houghton College in 1976 and obtained her doctorate from Pennsylvania State University College of Medicine in 1980.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/03/2024 | 260,000 ( 0.72% ) | 1 M $ | 30/03/2024 | |
INNOVIVA, INC.
0.09% | 21/05/2023 | 58,984 ( 0.09% ) | 898 916 $ | 30/03/2024 |
Deborah Birx active positions
| Companies | Position | Start |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Chief Executive Officer | 10/07/2023 |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Director/Board Member | - |
Former positions of Deborah Birx
| Companies | Position | End |
|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 09/07/2023 |
Training of Deborah Birx
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Deborah Birx
